Cargando…

Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer

BACKGROUND: Genetic alterations on chromosome 9p, including inactivation of the tumour suppressor gene, CDKN2A, result in cellular proliferation and growth of tumours. Our aim was to use microsatellite analysis and fluorescence in situ hybridization (FISH) to characterise the architecture of this re...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Mokadem, Ismail, Kidd, Thomas, Pratt, Norman, Fleming, Stewart, Nabi, Ghulam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341962/ https://www.ncbi.nlm.nih.gov/pubmed/27682877 http://dx.doi.org/10.18632/oncotarget.12196

Ejemplares similares

Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection
por: El-Mokadem, Ismail, et al.
Publicado: (2016)

Significance of Chromosome 9p Status in Renal Cell Carcinoma: A Systematic Review and Quality of the Reported Studies
por: El-Mokadem, Ismail, et al.
Publicado: (2014)

Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery
por: El-Mokadem, I, et al.
Publicado: (2014)

Chromosomal aberrations in renal cell carcinoma: An overview with implications for clinical practice
por: Quddus, Muhammad Bilal, et al.
Publicado: (2019)

Radiogenomics Reveals Correlation between Quantitative Texture Radiomic Features of Biparametric MRI and Hypoxia-Related Gene Expression in Men with Localised Prostate Cancer
por: Ogbonnaya, Chidozie N., et al.
Publicado: (2023)

High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.
por: Devlin, J., et al.
Publicado: (1996)

Tumour Suppressor Adenomatous Polyposis Coli (APC) localisation is regulated by both Kinesin-1 and Kinesin-2
por: Ruane, Peter T., et al.
Publicado: (2016)

Do Tumour Size, Type and Localisation Affect Resection Rate in Patients with Spinal Schwannoma?
por: Parlak, Ahmet, et al.
Publicado: (2022)

Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.
por: Viel, A., et al.
Publicado: (1992)

P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.
por: Dahiya, R., et al.
Publicado: (1996)

Preoperative imaging accuracy in size determination of prostate cancer in men undergoing radical prostatectomy for clinically localised disease
por: Ageeli, Wael, et al.
Publicado: (2023)

Selective Radionuclide Localisation in Primary Liver Tumours
por: Novell, J. R., et al.
Publicado: (1994)

Iodinated hydroxyphenyl and hydroxynaphthyl porphyrins as tumour localisers.
por: Zanelli, G. D., et al.
Publicado: (1990)

Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
por: van Wezel, Tom, et al.
Publicado: (2005)

Tumour Suppressor Mechanisms in the Control of Chromosome Stability: Insights from BRCA2
por: Venkitaraman, Ashok R.
Publicado: (2014)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

The Localisation of Tumours of the Spinal Cord Amenable to Surgical Treatment
por: Paton, E. Percy
Publicado: (1896)

Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
por: Dahran, Naief, et al.
Publicado: (2017)

Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.
por: Kuroki, T., et al.
Publicado: (1995)

The Localisation of the Lesions of Phthisis in Relation to Diagnosis and Prognosis
Publicado: (1888)

Recovery of immune competence after tumour resection in mice: correlation with loss of suppressor elements.
por: Gasocyne, R. D., et al.
Publicado: (1978)

The terminal region of the E. coli chromosome localises at the periphery of the nucleoid
por: Meile, Jean-Christophe, et al.
Publicado: (2011)

Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
por: Zuckermann, Marc, et al.
Publicado: (2015)

Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade
por: Appleton, Elizabeth, et al.
Publicado: (2021)

The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.
por: Meling, G. I., et al.
Publicado: (1993)

Immunohistochemical localisation of tissue plasminogen activator in human brain tumours.
por: Franks, A. J., et al.
Publicado: (1989)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Rolling out radioguided occult lesion localisation for breast tumours
por: Chung, David K V
Publicado: (2015)

The Diagnosis, Localisation, and Surgical Treatment of Tumours Pressing on the Spinal Cord
Publicado: (1892)

A Case of Cerebellar Tumour, Considered with Reference to Its Localisation
por: Bruce, Alexander, et al.
Publicado: (1899)

Characterisation of Collagen Re-Modelling in Localised Prostate Cancer Using Second-Generation Harmonic Imaging and Transrectal Ultrasound Shear Wave Elastography
por: Ageeli, Wael, et al.
Publicado: (2021)

Carcinoma In Situ Is Significantly Underdetected by Prenephroureterectomy Ureteroscopy in the Management of Upper Tract Urothelial Cancers
por: Gillan, Angela, et al.
Publicado: (2015)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter–22q11.2
por: Hulsebos, T J M, et al.
Publicado: (1999)

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
por: Defferrari, R, et al.
Publicado: (2015)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.
por: Hird, V., et al.
Publicado: (1991)

Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine.
por: Ometto, C., et al.
Publicado: (1996)

Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
por: Stintzing, Sebastian, et al.
Publicado: (2017)

Refractory hypoglycaemia in a localised gastrointestinal stromal tumour: Case report
por: Dhali, Arkadeep, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tqtbi5onkb78a09e6ncl1clhj2